磨玻璃样肺腺癌医患共同决策诊疗共识OA

With the popularization of low-dose computed tomography(LDCT)screening,the detection rate of ground-glass opacity(GGO)has been continuously increasing.Ground-glass opacity-featured lung adenocarcinoma is mostly characterized by indolent biological behavior and favorable prognosis.However,its progression is uncertain and recommenda-tions vary among guidelines.This places clinicians in a dilemma between timely intervention and avoiding overdiagnosis and overtreatment,while patients often suffer from follow-up anxiety and decision-making confusion.To standardize the whole-process management on an evidence-based basis and fully incorporate patient values,this expert consensus systematically re-views the entire procedure of GGO diagnosis and treatment,establishes shared decision-making between doctors and patients as the core principle,and emphasizes formulating management strategies by integrating patient values,life goals and risk prefer-ences.The consensus covers key components including the starting and ending ages for screening,limitations of imaging diag-nosis and indications for invasive diagnosis,indications and timing of surgery,strategies for sublobar resection and lymph node management,management of multiple GGOs,non-surgical alternative therapies,reliability of intraoperative frozen-section pathology,postoperative enhanced recovery and pain management,eligible populations for adjuvant therapy,and follow-up strategies.By promoting multidisciplinary collaboration and structured communication,this consensus aims to facilitate the transformation of the diagnosis and treatment model from disease-centered to patient value-centered,improve medical quality and patient satisfaction,reduce overtreatment,and promote doctor-patient harmony.